ZenNews› Health› NHS Rollout of MS Mobility Drug Raises Access Que… Health NHS Rollout of MS Mobility Drug Raises Access Questions Fampridine approval offers hope to thousands, but strict eligibility limits reach By Oliver Walsh Jul 27, 2026 1 min read Share Share X Facebook WhatsApp Copy link How do you feel about this? 🔥 0 😲 0 🤔 0 👍 0 😢 0 O Oliver Walsh Health & Climate Oliver Walsh analyses medical research, health policy and climate science. You might also like › Health NHS Waiting Times Crisis 2026 — Waiting Lists Hit Record High 05 Jul 2026 Health Maternity Review Fallout Puts Starmer's NHS Pledge to Test 04 Jul 2026 Health HPV Vaccine Cuts Cervical Cancer Deaths to Near Zero 26 Jun 2026 Health NHS Launches Drug to Delay Type 1 Diabetes Onset 26 Jun 2026 Health Wegovy Pill Form Signals Shift in NHS Obesity Strategy 23 Jun 2026 Health NHS Corridor Care Crisis Deepens as Daily Toll Hits 3,000 22 Jun 2026 Health NHS GP Surgery Closures at Record High — Millions Lose Access to Local Doctor 30 May 2026 Health Fit Note System 'Broken', Says Government as Pilot Scheme Launched 21 May 2026 Also interesting › Society Jewish Students Report Rising Fear on UK Campuses 3 hrs ago Tech Starmer Faces Pressure Over UK AI Safety Rules After OpenAI Hack 4 hrs ago UK Politics Lewisham's Immigration Stand Sets Up Legal Clash With Whitehall Yesterday UK Politics Burnham's Northern Focus Tests Traditional Westminster Governing Yesterday More in Health › Health NHS Waiting Times Crisis 2026 — Waiting Lists Hit Record High 05 Jul 2026 Health Maternity Review Fallout Puts Starmer's NHS Pledge to Test 04 Jul 2026 Health HPV Vaccine Cuts Cervical Cancer Deaths to Near Zero 26 Jun 2026 Health NHS Launches Drug to Delay Type 1 Diabetes Onset 26 Jun 2026 ← Health NHS Waiting Times Crisis 2026 — Waiting Lists Hit Record High
